Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$27.45−1.09 (-3.82%)
Close on Nov 17, 2026Market cap $1.33BP/E –Yield –
Nanobiotix ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -€9.32M. The highest annual figure on record is -€9.32M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€9.32M | – |
| FY2024 | Dec 31, 2024 | -€66.77M | – |
| FY2023 | Dec 31, 2023 | -€25.27M | – |
| FY2022 | Dec 31, 2022 | -€45.20M | – |
| FY2021 | Dec 31, 2021 | -€51.02M | – |
| FY2020 | Dec 31, 2020 | -€34.67M | – |
| FY2019 | Dec 31, 2019 | -€45.01M | – |
| FY2018 | Dec 31, 2018 | -€29.45M | – |
See a number that looks wrong?